Uncategorized

FactSet Names Helen Shan As Chief Revenue Officer

byBenzinga Newsdesk

April 20, 2021

0 minute read

Hepion Pharmaceuticals Says Co’s Anti-Cancer Mechanism CRV431 Highlighted In Scripps Research Institute Poster At AASLD, The Liver Meeting 2021

By Benzinga Newsdesk

Today, 4:54 AM

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence ("AI")-driven therapeutic drug development for the treatment of non-alcoholic

HEPA

Deutsche Bank Maintains Buy on Activision Blizzard, Lowers Price Target to $95

By Benzinga Newsdesk

Today, 4:54 AM

Deutsche Bank maintains Activision Blizzard (NASDAQ:ATVI) with a Buy and lowers the price target from $115 to $95.

ATVI

Morgan Stanley Maintains Overweight on Domino’s Pizza, Lowers Price Target to $541

By Benzinga Newsdesk

Today, 4:54 AM

Morgan Stanley analyst John Glass maintains Domino's Pizza (NYSE:DPZ) with a Overweight and lowers the price target from $559 to $541.

DPZ

Analyst Ratings

9 Analysts Have This to Say About Sherwin-Williams

By Benzinga Insights

Today, 4:54 AM

Over the past 3 months, 9 analysts have published their opinion on Sherwin-Williams (NYSE:SHW) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

SHW

FactSet Names Helen Shan As Chief Revenue Officer

Related Posts

Hepion Pharmaceuticals Says Co’s Anti-Cancer Mechanism CRV431 Highlighted In Scripps Research Institute Poster At AASLD, The Liver Meeting 2021

Deutsche Bank Maintains Buy on Activision Blizzard, Lowers Price Target to $95

Morgan Stanley Maintains Overweight on Domino’s Pizza, Lowers Price Target to $541

9 Analysts Have This to Say About Sherwin-Williams